Search Results - "Cucurull, Marc"

Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack? by Plaja, Andrea, Moran, Teresa, Carcereny, Enric, Saigi, Maria, Hernández, Ainhoa, Cucurull, Marc, Domènech, Marta

“…Small-cell lung cancer (SCLC) is an aggressive malignancy characterized by a rapid progression and a high resistance to treatments. Unlike other solid tumors,…”
Get full text

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies by Cucurull, Marc, Notario, Lucia, Sanchez-Cespedes, Montse, Hierro, Cinta, Estival, Anna, Carcereny, Enric, Saigí, Maria

“…Approximately 20% of lung adenocarcinomas harbor mutations, an oncogene that drives tumorigenesis and has the ability to alter the immune system and the tumor…”
Get full text

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors by Felip, Eudald, Pradenas, Edwards, Romeo, Margarita, Marfil, Silvia, Trinité, Benjamin, Urrea, Víctor, Hernández, Ainhoa, Ballana, Ester, Cucurull, Marc, Mateu, Lourdes, Massanella, Marta, Clotet, Bonaventura, Morán, Teresa, Blanco, Julià

“…Patients with solid tumors have been a risk group since the beginning of the SARS‐CoV‐2 pandemic due to more significant complications, hospitalizations or…”
Get full text

Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery by Plaja, Andrea, Teruel, Iris, Ochoa-de-Olza, Maria, Cucurull, Marc, Arroyo, Álvaro Javier, Pardo, Beatriz, Ortiz, Irene, Gil-Martin, Marta, Piulats, Josep María, Pla, Helena, Fina, Claudia, Carbó, Anna, Barretina-Ginesta, Maria-Pilar, Martínez-Román, Sergio, Carballas, Elvira, González, Andrea, Esteve, Anna, Romeo, Margarita

“…Despite a multimodal radical treatment, mortality of advanced epithelial ovarian cancer (AEOC) remains high. Host-related factors, such as systemic…”
Get full text

Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C by Notario, Lucía, Cucurull, Marc, Cerdà, Gabriela, Sanz, Carolina, Carcereny, Enric, Muñoz-Mármol, Ana, Hernández, Ainhoa, Domènech, Marta, Morán, Teresa, Sánchez-Céspedes, Montse, Costa, Marta, Mate, Jose-Luis, Esteve, Anna, Saigí, Maria

“…Approximately 20% of lung adenocarcinomas harbor activating mutations at KRAS , an oncogene with the ability to alter the tumor immune microenvironment. In…”
Get full text

Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma? by Chekhun, Sviatoslav, Lopez-Paradís, Assumpció, Urbizu, Aintzane, Morán, Teresa, Mañes, Anabel, Cucurull, Marc, Martínez-Barenys, Carlos, Teruel, Iris, Moragas, Gloria, Carcereny, Enric, Muñoz Mármol, Ana Maria, Saigí, Maria

“…Third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have shown impressive results in mutant lung cancer (LC) patients in…”
Get full text

Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study by Candal-Pedreira, Cristina, Ruano-Ravina, Alberto, Calvo de Juan, Virginia, Cobo, Manuel, Trigo, José Manuel, Carcereny, Enric, Cucurull, Marc, López Castro, Rafael, Solís García, Eduardo, Sánchez-Gastaldo, Amparo, Massutí, Bartomeu, Rodríguez-Abreu, Delvys, Estival, Anna, Guirado Risueño, María, Pamiés Ramón, María, García Campelo, Rosario, Alonso-Jáudenes, Guillermo, Camps, Carlos, Del Barco Morillo, Edel, González Ojea, Clara, Dómine, Manuel, Sanchez-Hernandez, Alfredo, Bosch-Barrera, Joaquím, Sala González, María Ángeles, Provencio, Mariano

“…The aim of the study was to ascertain the percentage of Spanish lung cancer cases that would fulfil the lung cancer screening inclusion criteria recommended by…”
Get full text

Therapeutic options for lung cancer with ALK or ROS1 (+) rearrangement. First line and progression management by Carcereny, Enric, Cucurull, Marc, Guillen, Pau

Get full text

HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer by Saigí, Maria, Mate, Jose L., Carcereny, Enric, Martínez-Cardús, Anna, Esteve, Anna, Andreo, Felipe, Centeno, Carmen, Cucurull, Marc, Mesia, Ricard, Pros, Eva, Sanchez-Cespedes, Montse

“…•Additional predictive markers besides to PD-L1 are needed to select patients with NSCLC more accurately who would benefit from ICI strategies.•High levels of…”
Get full text

Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer by Saigí, Maria, Carcereny, Enric, Morán, Teresa, Cucurull, Marc, Domènech, Marta, Hernandez, Ainhoa, Martinez-Cardús, Anna, Pros, Eva, Sanchez-Cespedes, Montse

“…•Gene fusions and amplifications often activate receptor tyrosine kinases in lung cancer.•Next-generation sequencing is the gold standard for molecular…”
Get full text

Lung cancer patients with COVID-19 in Spain: GRAVID study by Provencio, Mariano, Mazarico Gallego, José María, Calles, Antonio, Antoñanzas, Mónica, Pangua, Cristina, Mielgo Rubio, Xabier, Nadal, Ernest, Castro, Rafael López, López-Martín, Ana, del Barco, Edel, Dómine, Manuel, Franco, Fernando, Diz, Pilar, Sandoval, Carmen, Girona, Elia Sais, Sullivan, Ivana, Sala, Mª Ángeles, Ledo, Gema García, Cucurull, Marc, Mosquera, Joaquín, Martínez, Mireia, Chara, Luis Enrique, Arriola, Edurne, Herrera, Beatriz Esteban, Jarabo, José Ramón, Álvarez, Rosa Álvarez, Baena, Javier, Cao, María González

“…•GRAVID reports one of the largest series of patients with lung cancer and COVID-19.•Of 447 patients, 78 % were hospitalized, 2% were admitted to ICU and 33 %…”
Get full text

Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study by Hernandez, Ainhoa, Boigues, Marc, Felip, Eudald, Cucurull, Marc, Notario, Lucia, Pous, Anna, Torres, Pere, Benitez, Marta, Rodriguez, Marina, Quirant, Bibiana, Romeo, Margarita, Fuster, Daniel, Moran, Teresa

“…Lung cancer patients represent a subgroup of special vulnerability in whom the SARS-CoV-2 infection could attain higher rates of morbidity and mortality…”
Get full text

Prognostic value of monocyte to lymphocyte ratio (MLR) in epithelial ovarian cancer (EOC) by Cucurull, Marc, Felip, Eudald, Garcia, Juan Jose, Erasun, Carlos, Angelats, Laura, Teruel, Iris, Martinez-Román, Sergi, Hernández, Joaquin, Esteve, Anna, España, Sofia, Romeo, Margarita

“…Abstract only e17066 Background: Identifying high-risk early-stage EOC patients (p) is a major issue. Also, controversy about the role of neoadjuvant…”
Get full text

Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients by Hardy-Werbin, Max, Quiroga, Vanesa, Cirauqui, Beatriz, Romeo, Margarita, Felip, Eudald, Teruel, Iris, Garcia, Juan Jose, Erasun, Carlos, España, Sofia, Cucurull, Marc, Montprade, Elisabeth, Pardo, Juan Carlos, Carballo, Dania, Velarde, Jose Maria, Margeli, Mireia

“…T-DM1 is an antibody drug conjugate that combines trastuzumab with emtansine via a stable thioether linker. In two phase III clinical trials, EMILIA and…”
Get full text

Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver by Domènech, Marta, Muñoz Marmol, Ana M., Mate, Jose Luis, Estival, Anna, Moran, Teresa, Cucurull, Marc, Saigi, Maria, Hernandez, Ainhoa, Sanz, Carolina, Hernandez-Gallego, Alba, Urbizu, Aintzane, Martinez-Cardus, Anna, Bernat, Adrià, Carcereny, Enric

“…Non-small cell lung cancers (NSCLC) are the most common type of lung cancer and can be classified according to the presence of mutually exclusive oncogenic…”
Get full text

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer by Aparicio, Inmaculada, Iranzo, Patricia, Reyes, Roxana, Bote, Helena, Saigi, María, Bringas, Marianela, Bosch-Barrera, Joaquim, Corral, Jesús, Aparisi, Francisco, Ruffinelli, Jose C., Jiménez, Beatriz, Lage, Yolanda, López-Castro, Rafael, Majem, Margarita, Vázquez, Sergio, Artal, Ángel, Rodríguez-Pérez, Ángel, Lázaro-Quintela, Martín, Torres, José Miguel Sánchez, Reguart, Noemí, Cucurull, Marc, Gil-Bazo, Ignacio, Camps, Carlos, Nadal, Ernest, del Barrio, Anabel, Garrido, Pilar, Dómine, Manuel, Álvarez, Rosa, Muñoz, Andrés J., Calles, Antonio

“…INTRODUCTIONWe aimed to determine if advanced BRAF-mutant NSCLC has a higher thromboembolic events (TEE) rate than the expected.METHODSBetween 2008 and 2021,…”
Get full text

Clinical algorithm to predict who may benefit from CDK4/6 inhibitors in patients (p) with estrogen receptor positive and HER-2 negative (ER+/Her2-) metastatic breast cancer (MBC) by Felip-Falgàs, Eudald, Teruel, Iris, García Mosquera, Juan José, Erasun, Carlos, Quiroga Garcia, Vanesa, Angelats, Laura, España, Sofia, Cucurull, Marc, Cirauqui, Beatriz, Vila, Mireia Margeli

“…Abstract only…”
Get full text

Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen by Pous, Anna, Izquierdo, Cristina, Cucurull, Marc, Sánchez, Silvia, Lezcano, Clara, Domenech, Marta, Llobera, Laia, Plaja, Andrea, Moran, Teresa

“…Alternative dosage regimens for some anticancer therapies have been proposed in the midst of the SARS-COV-2 pandemic in order to protect the patients from…”
Get full text

Prognostic factors in patients with uterine sarcoma: the SARCUT study by Zapardiel, Ignacio, Gracia Segovia, Myriam, Macuks, Ronalds, Mancari, Rosanna, Achimas-Cadariu, Patriciu, Corrado, Giacomo, Bartusevicius, Arnoldas, Sukhin, Vladyslav, Muruzabal, Juan C, Coronado Martín, Pluvio J, Gardella, Barbara, Piek, Jurgen M, Concin, Nicole, Arab, Clemente, Papatheodorou, Dimitrios, Polterauer, Stephan, Iacoponi, Sara, Nieto, Teresa, Lopez-Sanclemente, Martha C, Trukhan, Hanna, Gil, Maria M, Bakinovskaya, Irina, Dalamanava, Alena, Cucurull, Marc, Rovski, Dzmitry, Baquedano, Laura, Chiva, Luis, Mardas, Marcin, Mavrichev, Siarhei Anatolievich, Klat, Jaroslav, Lopez de la Manzanara, Carlos A, Yildirim, Yusuf

“…Uterine sarcomas are a rare and heterogeneous group of malignancies that include different histological sub-types. The aim of this study was to identify and…”
Get more information

Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients by Candal-Pedreira, Cristina, Ruano-Ravina, Alberto, Calvo de Juan, Virginia, Cobo, Manuel, Trigo, José Manuel, Rodríguez-Abreu, Delvys, Estival, Anna, Carcereny, Enric, Cucurull, Marc, López Castro, Rafael, Medina, Andrea, García Campelo, Rosario, Cordeiro González, Patricia, Sánchez-Gastaldo, Amparo, Bosch-Barrera, Joaquim, Massutí, Bartomeu, Dómine, Manuel, Camps, Carlos, Ortega, Ana Laura, Sánchez-Hernández, Alfredo, Guirado Risueño, María, del Barco Morillo, Edel, Garrido Fernández, Alberto, Provencio, Mariano

“…[Display omitted] The aim of this study was to analyze the clinical and genetic characteristics of young lung cancer cases, and to compare them with those of…”
Get full text